Computer-aided Drug Discovery Market worth $7.16 billion by 2030, growing at a CAGR of 9.71% - Exclusive Report by 360iResearch

The "Computer-aided Drug Discovery Market by Type (Ligand-Based Drug Design, Sequence-Based Approaches, Structure-Based Drug Design), Therapeutic Area (Cardiovascular Disease, Diabetes, Neurology), End User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/computer-aided-drug-discovery

Computer-aided Drug Discovery (CADD) utilizes computational methods and tools in drug identification and development, encompassing computational chemistry, biology, and informatics to enhance efficiency and streamline processes. Techniques include molecular modeling, simulations, virtual screening, and quantitative structure-activity relationships (QSAR), aiming to reduce costs and time while improving success rates. CADD is essential for enhancing predictive accuracy, resource optimization, and early failure identification. Applications range from lead identification and optimization to molecular docking and pharmacophore modeling. Pharmaceutical companies, biotechnology firms, academic institutes, and contract research organizations (CROs) comprise the primary end-users leveraging CADD to streamline pipelines and foster therapeutic innovation. Key growth factors include advancements in technology, rising healthcare demands, regulatory support, and increased collaboration between tech and pharmaceutical sectors. Opportunities lie in integrating AI and ML for predictive analytics, expanding into personalized medicine, utilizing cloud computing for scalable processes, and developing open-source platforms for collaboration. Recommendations emphasize investing in AI, fostering cross-industry partnerships, focusing on rare diseases, and adopting agile methodologies to enhance efficiency. However, challenges such as data quality, biological system complexity, high initial costs, regulatory hurdles, interdisciplinary expertise requirements, and resistance to traditional methods pose limitations. Areas for innovation include AI/ML models for molecular predictions, quantum computing for complex simulations, multi-omics integration for comprehensive drug discovery, and blockchain technology to ensure data integrity. The CADD market is highly dynamic and evolving, driven by technological advancements and growing demand for cost-effective drug discovery, comprising established pharmaceutical companies, biotech startups, and specialized computational chemistry firms, with increasing investments and partnerships pushing boundaries in multidisciplinary integration and big data applications.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/computer-aided-drug-discovery

Market Segmentation & Coverage:

This research report categorizes the Computer-aided Drug Discovery Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Ligand-Based Drug Design, Sequence-Based Approaches, and Structure-Based Drug Design.

Based on Therapeutic Area, market is studied across Cardiovascular Disease, Diabetes, Neurology, Oncology, and Respiratory Disease.

Based on End User, market is studied across Biotechnology Companies, Pharmaceutical Companies, and Research Laboratories.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Profiles:

The report delves into recent significant developments in the Computer-aided Drug Discovery Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accelrys, Inc., AstraZeneca PLC, Bayer AG, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Chemical Computing Group Inc., Dassault Systèmes SE, Eli Lilly and Company, Gilead Sciences, Inc., GlaxoSmithKline PLC, Merck & Co., Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Roche Holding AG, Sanofi S.A., Schrodinger, Inc., Simulations Plus, Inc., and Vertex Pharmaceuticals Incorporated.

Introducing 360iResearch AI: Revolutionizing Market Intelligence with AI-Powered Insights for the Computer-aided Drug Discovery Market

We proudly unveil Research AI, a cutting-edge AI product designed to transform how businesses interact with the Computer-aided Drug Discovery Market. Research AI stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, Research AI is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Computer-aided Drug Discovery Market. Embrace the future of market analysis with Research AI, where informed decisions lead to remarkable growth.

Ask Question to Research AI @ https://www.360iresearch.com/library/intelligence/computer-aided-drug-discovery

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Computer-aided Drug Discovery Market, by Type
7. Computer-aided Drug Discovery Market, by Therapeutic Area
8. Computer-aided Drug Discovery Market, by End User
9. Americas Computer-aided Drug Discovery Market
10. Asia-Pacific Computer-aided Drug Discovery Market
11. Europe, Middle East & Africa Computer-aided Drug Discovery Market
12. Competitive Landscape
13. Competitive Portfolio

Read More @ https://www.360iresearch.com/library/intelligence/computer-aided-drug-discovery

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.